(Q51060013)
Statements
Genetic determinants of responsiveness to the HMG-CoA reductase inhibitor fluvastatin in patients with molecularly defined heterozygous familial hypercholesterolemia (English)
Leitersdorf E
Eisenberg S
Eliav O
Friedlander Y
Berkman N
Dann EJ
Landsberger D
Sehayek E
Meiner V